The Target Newsletter: Radiation Therapy with Heavy Ions: Physical, Biological and Clinical Rationale (EM1603A)

Brain metastasis may occur in 10-30% of all cancer patients, and the prognosis is generally poor, with median survival of only a few months. Treatments can vary widely, ranging from close observation to multimodality therapy including surgery, radiation and even chemotherapy. An understanding of the radiotherapy treatment options should help physicians in managing the overall care of their patients.

The Target Newsletter is designed to familiarize the learner with the appropriate use of radiation therapy for the management of different types of cancers. This may include the combination of radiotherapy with other therapies, use of particular advanced technologies, outcomes for specific disease sites, and general best practices.

Target Audience

This activity is targeted to radiation oncologists, medical oncologists, surgical oncologists, neuro-oncologists, family medicine, generalists, radiation therapists, residents, and medical students.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Differentiate the physical & biological characteristics of ion beam therapy from those of standard electron or photon therapy
  • Identify tumor types well-suited to ion beam therapy
  • Discuss the current state of clinical experience with ion therapy

Method of Participation

This continuing medical education enduring material is an article of the TARGET Journal, University of Texas Southwestern Medical Center, Dallas, Texas.  

  1. Read the article.
  2. Take the post-test.  A passing score of 80% is required to earn credit.  The test can be retaken until passing.
  3. Complete the evaluation.
  4. Claim CME credit.
  5. This activity should take 30 minutes to complete.
Course summary
Available credit: 
  • 0.50 AMA
  • 0.50 Attendance
Course opens: 
03/23/2015
Course expires: 
03/23/2015
Cost:
$0.00

Faculty:
Lucien Nedzi, M.D.
Associate Professor and Medical Director
Department of Radiation Oncology
Disclosure: Research Activity – Bristol-Myers Squibb, Celgene

Authors:
Arnold Pompos
Assistant Professor
Department of Radiation Oncology
Disclosure: Nothing to disclose

Jeffrey Meyer
Assistant Professor
Department of Radiation Oncology
Disclosure: Nothing to disclose

Accreditation Statement

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Available Credit

  • 0.50 AMA
  • 0.50 Attendance

Accreditation Period

Course opens: 
03/23/2015
Course expires: 
03/23/2015

Price

Cost:
$0.00
Please login or create an account to take this course.